Eiji Nishiwaki

941 total citations
17 papers, 787 citations indexed

About

Eiji Nishiwaki is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Eiji Nishiwaki has authored 17 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Eiji Nishiwaki's work include DNA and Nucleic Acid Chemistry (3 papers), Metal complexes synthesis and properties (2 papers) and Cancer therapeutics and mechanisms (2 papers). Eiji Nishiwaki is often cited by papers focused on DNA and Nucleic Acid Chemistry (3 papers), Metal complexes synthesis and properties (2 papers) and Cancer therapeutics and mechanisms (2 papers). Eiji Nishiwaki collaborates with scholars based in Japan, United States and Russia. Eiji Nishiwaki's co-authors include Masayuki Shibuya, Yasuyuki Kirii, Koichi Yokota, Hiroshi Ohmoto, Shigeki Higashiyama, Kiyoshi Yoshino, Hiroshi Ishiguro, Masaki Gouda, Shigeaki Tanaka and Hirohide Sawada and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Eiji Nishiwaki

17 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiji Nishiwaki Japan 14 395 195 190 95 93 17 787
Paul Tapang United States 14 444 1.1× 143 0.7× 236 1.2× 43 0.5× 39 0.4× 29 773
Carol Torcellini United States 10 290 0.7× 231 1.2× 103 0.5× 226 2.4× 83 0.9× 13 801
Dario Ballinari Italy 19 608 1.5× 178 0.9× 400 2.1× 33 0.3× 129 1.4× 54 1.1k
Steve Tam United States 20 553 1.4× 435 2.2× 195 1.0× 56 0.6× 62 0.7× 29 1.1k
Timothy P. Kogan United States 21 543 1.4× 397 2.0× 97 0.5× 129 1.4× 101 1.1× 38 1.2k
Michiko Tajiri Japan 19 1.1k 2.7× 220 1.1× 100 0.5× 75 0.8× 71 0.8× 36 1.4k
Johann Rastetter Germany 18 590 1.5× 189 1.0× 269 1.4× 53 0.6× 54 0.6× 72 1.1k
Lois M. Hinman United States 15 664 1.7× 141 0.7× 551 2.9× 94 1.0× 151 1.6× 30 1.6k
B Barbieri Italy 11 271 0.7× 102 0.5× 151 0.8× 39 0.4× 45 0.5× 20 604
André Richters Germany 17 480 1.2× 212 1.1× 144 0.8× 20 0.2× 44 0.5× 24 776

Countries citing papers authored by Eiji Nishiwaki

Since Specialization
Citations

This map shows the geographic impact of Eiji Nishiwaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Nishiwaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Nishiwaki more than expected).

Fields of papers citing papers by Eiji Nishiwaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiji Nishiwaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Nishiwaki. The network helps show where Eiji Nishiwaki may publish in the future.

Co-authorship network of co-authors of Eiji Nishiwaki

This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Nishiwaki. A scholar is included among the top collaborators of Eiji Nishiwaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Nishiwaki. Eiji Nishiwaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ozeki, Keiji, Satoshi Tanida, Chie Morimoto, et al.. (2013). Telmisartan Inhibits Cell Proliferation by Blocking Nuclear Translocation of ProHB-EGF C-Terminal Fragment in Colon Cancer Cells. PLoS ONE. 8(2). e56770–e56770. 20 indexed citations
2.
Ohnuki, Hidetaka, Hirofumi Inoue, Nobuaki Takemori, et al.. (2012). BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesis. Blood. 119(11). 2688–2698. 48 indexed citations
3.
Yokota, Koichi, et al.. (2012). Activity‐based kinase profiling of approved tyrosine kinase inhibitors. Genes to Cells. 18(2). 110–122. 173 indexed citations
4.
Kawase, Yusuke, Koichi Yokota, Yasuyuki Kirii, et al.. (2003). Exacerbated and Prolonged Allergic and Non-Allergic Inflammatory Cutaneous Reaction in Mice with Targeted Interleukin-18 Expression in the Skin. Journal of Investigative Dermatology. 121(3). 502–509. 45 indexed citations
5.
Mori, Seiji, Motonari Tanaka, Daisuke Nanba, et al.. (2003). PACSIN3 Binds ADAM12/Meltrin α and Up-regulates Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor. Journal of Biological Chemistry. 278(46). 46029–46034. 71 indexed citations
6.
Kawase, Yusuke, Tomoaki Hoshino, Koichi Yokota, et al.. (2003). Bone Malformations in Interleukin-18 Transgenic Mice. Journal of Bone and Mineral Research. 18(6). 975–983. 28 indexed citations
7.
Sawa, Masaaki, Takao Kiyoi, Minoru Yamamoto, et al.. (2002). New Type of Metalloproteinase Inhibitor:  Design and Synthesis of New Phosphonamide-Based Hydroxamic Acids. Journal of Medicinal Chemistry. 45(4). 919–929. 93 indexed citations
8.
Nishii, Kazuhiro, Kouji Yamada, Hirohide Sawada, et al.. (2002). Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity. Gene. 282(1-2). 227–236. 103 indexed citations
9.
Nishiwaki, Eiji, S L Turner, Susanna Harju, et al.. (2000). Regulation of CDK7–Carboxyl-Terminal Domain Kinase Activity by the Tumor Suppressor p16INK4A Contributes to Cell Cycle Regulation. Molecular and Cellular Biology. 20(20). 7726–7734. 21 indexed citations
10.
Sakai, Yasuhiro, Eiji Nishiwaki, Kozo Shishido, Masayuki Shibuya, & Masaru Kido. (1991). Synthesis of a sulfulr-containing 10-membered enediyne model compound related to the esperamicin/calicheamicin/dynemicin agylcones. Tetrahedron Letters. 32(34). 4363–4366. 31 indexed citations
12.
Shibuya, Masayuki, et al.. (1990). Synthesis of Novel 1,2,4-Triazole-containing Oligopeptides. Heterocycles. 31(9). 1629–1629. 9 indexed citations
13.
Nishiwaki, Eiji, et al.. (1990). Synthesis of nitrated oligo-N-methylpyrrole carboxamide derivatives and their photochemical DNA cleaving activities. Tetrahedron Letters. 31(9). 1299–1302. 23 indexed citations
14.
Shibuya, Masayuki, et al.. (1990). Synthesis of Oligo-N-methylpyrrolecarboxamide Derivatives and Their Photochemical DNA Cleaving Activities. Heterocycles. 31(10). 1763–1763. 18 indexed citations
15.
Shibuya, Masayuki, et al.. (1988). Efficient Synthesis of Oligo-N-methylpyrrolecarboxamides and Relateed Compounds. Heterocycles. 27(8). 1945–1945. 65 indexed citations
16.
Shibuya, Masayuki, Hiromu Sakurai, Toshio Maeda, Eiji Nishiwaki, & Masako Saitō. (1986). Synthesis of the degradation product of auromomycin chromophore and DNA-cleaving activities of its derivatives. Tetrahedron Letters. 27(12). 1351–1354. 10 indexed citations
17.
Nakamura, Mariko, Maho Morita, Eiko Yabuuchi, et al.. (1982). [The evaluation and the results of cooperative cholesterol and triglyceride standardization program by WHO-CDC (author's transl)].. PubMed. 30(3). 325–32. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026